by Steven A. Grossman | Apr 4, 2025 | Short Takes and Updates
— First appeared in Food Safety News. Reprinted with permission. — Secretary Kennedy’ announcement came last Thursday: FDA’s contribution to the pending HHS reduction in force (RIF) would be 3,500 employees. That is not quite 20% of the agency’s total workforce....
by Steven A. Grossman | Apr 2, 2025 | Short Takes and Updates
— Permission is granted to reprint or recirculate this column, as long as attribution is made to FDA Matters (www.fdamatters.com) and the author. — Smaller government is possible, albeit not always warranted. In theory, you could RIF 3,500 FDA employees and...
by Steven A. Grossman | Mar 29, 2025 | Short Takes and Updates
— A Tribute to Dr. Peter Marks — If things went really bad at FDA, who would still be there at the end—caring enough about the agency and public health to keep fighting? My answer would be Dr. Peter Marks. I know you would agree.Peter has been grace and...
by Steven A. Grossman | Mar 28, 2025 | Short Takes and Updates
Lots of media inquiries yesterday about the consequences of the HHS RIF announcement (Announcement, Fact Sheet). Here is what I told reporters: “The FDA’s portion of the reduction in force is 3,500 and that would be in addition to those who took buyouts...
by Steven A. Grossman | Mar 28, 2025 | Uncategorized
Targeting FDA user fees would leave agency gutted, experts saySteven Grossman, a regulatory consultant at HPS Group and author of the FDA Matters newsletter, said in an email to CQ Roll Call that his concerns about the future of the user fee program have grown since...
